等待开盘 11-17 09:30:00 美东时间
-0.034
-5.05%
Connect Biopharma reported positive Phase 2 Seabreeze STAT study results for rademikibart as an adjunct treatment for acute exacerbations of asthma and COPD. The study showed significant improvements in lung function, reduced treatment failures, and no hospitalizations in COPD patients. The company plans to meet with the FDA in December 2026 for asthma and Q1 2027 for COPD to discuss potential Phase 3 programs. Financially, the company had $19.5 ...
11-16 21:05
11月14日,康乃德生物医药(CNTB)收涨1.79%,报0.68美元,成交额15.85万美元,市值4264.64万美元。 行情数据 • 开盘价:0.68美元...
11-14 08:27
11月7日,康乃德生物医药(CNTB)收跌0.41%,报0.73美元,成交额24.62万美元,市值4588.18万美元。 行情数据 • 开盘价:0.75美元 ...
11-07 08:20
10月31日,康乃德生物医药(CNTB)收跌3.97%,报0.8美元,成交额202.18万美元,市值5051.78万美元。 行情数据 • 开盘价:0.83美元...
10-31 07:22
10月23日,康乃德生物医药(CNTB)收跌4.51%,报0.76美元,成交额81.2万美元,市值4799.27万美元。 行情数据 • 开盘价:0.8美元 •...
10-23 07:27
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:24
今日重点评级关注:摩根士丹利:维持TeraWulf"超配"评级,目标价从62.5美元升至65美元;摩根士丹利:维持Hut 8"超配"评级,目标价从273美元升至275美元
10-13 12:30
Leerink Partners analyst Will Soghikian assumes Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform rating and announces Price Target of $4.
10-12 20:27
今日重点评级关注:Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从14.5美元升至15美元;摩根大通:维持Annexon"超配"评级,目标价从14美元升至15美元
10-01 19:18
BTIG analyst Julian Harrison maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and lowers the price target from $10 to $5.
10-01 00:54